MB Venture Capital

MB Venture Capital, Merlin Biosciences Fund and 3i raise £10.5m for Onyvax. Onyvax advised by Weil Gotshal & Manges (Paul Claydon). Investors advised by Taylor Vinters, KLegal and Osborne Clarke OWA respectively.